跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,768 条关于
“Lysine-280”
全部
8,768
临床试验
6,870
药物
892
机构
22
资讯
984
去年
Anti-Tau Antibodies Show Promise in Targeting Alzheimer's Disease Pathologies
9个月前
Sanofi Secures $1.04 Billion License for ADEL-Y01, Novel Tau-Targeting Alzheimer's Therapy
去年
Incyte Settles $280 Million Royalty Dispute with Novartis Over Jakafi
上个月
TD Cowen Initiates Buy Rating on AbbVie with $280 Price Target
去年
Incyte to Pay Novartis $280M in Settlement Over Jakafi Royalty Dispute
去年
AstraZeneca Halts Phase 3 Trial of Capivasertib for Metastatic Castration-Resistant Prostate Cancer
去年
Salarius Pharmaceuticals' Seclidemstat Gains Validation as LSD1 Inhibitor in New Studies While Phase 1/2 Trial Advances
去年
AstraZeneca Discontinues Phase 3 Trial of Truqap for Metastatic Prostate Cancer
去年
NIH Grants Exclusive License to Sangam Lifesciences for Novel Cancer Drug Delivery Platform
去年
Lighthouse Pharmaceuticals Secures $49.2 Million NIH Grant for Novel Alzheimer's Disease Treatment Targeting Bacterial Infection
第 1 页,共 99 页
上一页
下一页